Skip to main content
. 2019 Feb 26;20:69. doi: 10.1186/s12882-019-1257-6

Table 4.

Substrates, inducers and inhibitors of the cytochrome P450 enzymatic pathways [21, 23]

CYP3A4 substrates Inducers Inhibitors
Statins (simvastatin, atorvastatin, lovastatin)
Elvitegravir
Hormonal contraceptives
Corticosteroids (budesonide, fluticasone, triamcinolone)
Direct Xa inhibitors (rivaroxaban, apixaban)
Dihydropyridine calcium channel blockers (nifedipine, felodipine)
Antiarrhythmic (amiodarone, propafenone, flecainide)
Benzodiazepines (midazolam, alprazolam, triazolam)
Anti-epileptic drugs (carbamazepine, phenytoin, phenobarbital)
Rifabutin, Rifampin
Dexamethasone
Omeprazole
Non-nucleoside reverse transcriptase inhibitors (efavirenz, nevirapine, etravirine)
Azoles antifungals (fluconazole, itraconazole, ketoconazole)
Macrolides (erythromycin, clarithromycin, azithromycin)
Antidepressants (tricyclic, venlafaxine, fluoxetine, sertraline)
Calcineurin inhibitors (cyclosporine, tacrolimus)
Nondihydropyridine calcium channel blockers (verapamil, diltiazem)
Amiodarone
Protease inhibitors (indinavir, amprenavir, nelfinavir, saquinavir, atazanavir, ritonavir)
Cobicistat
Grapefruit juice